Alterations in 5‐HT2A receptor binding in various brain regions among 6‐hydroxydopamine‐induced Parkinsonian rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Synapse

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1002/syn.20722PMID 19862688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.

  2012cited by this paper
• The frontostriatal circuitry and behavioral complications in PD.

  2012cited by this paper
• NMDA Receptors in Retrosplenial Cortex Are Necessary for Retrieval of Recent and Remote Context Fear Memory

  2011cited by this paper
• MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity.

  2011cited by this paper
• Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

  2011cited by this paper
• Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses

  2011cited by this paper
• Role of Spinal Neurotransmitter Receptors in Itch: New Insights into Therapies and Drug Development

  2011cited by this paper
• Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.

  2011cited by this paper
• Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.

  2011cited by this paper
• Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.

  2011cited by this paper
• Searching for Presynaptic NMDA Receptors in the Nucleus Accumbens

  2011cited by this paper
• Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

  2010cited by this paper
• High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain.

  2009cited by this paper
• Cognitive impairment in incident, untreated Parkinson disease

  2009cited by this paper
• Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.

  2009cited by this paper
• Effects of chronic treatment of olanzapine and haloperidol on peptide YY binding densities in the rat brain.

  2008cited by this paper
• HRONIC TREATMENT WITH SIMVASTATIN UPREGULATES USCARINIC M1/4 RECEPTOR BINDING IN THE RAT BRAIN

  2008cited by this paper
• Epidemiology of Parkinson’s disease

  2008cited by this paper
• Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

  2008cited by this paper
• Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability.

  2008cited by this paper
• Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.

  2008cited by this paper
• Brain imaging in patients with freezing of gait

  2008cited by this paper
• Non-dopaminergic treatments in development for Parkinson's disease.

  2008cited by this paper
• Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.

  2008cited by this paper
• Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in l-DOPA treatment of an animal model of Parkinsonism

  2008cited by this paper
• Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.

  2007cited by this paper
• Caloric restriction eliminates the aging-related decline in NMDA and AMPA receptor subunits in the rat hippocampus and induces homeostasis.

  2007cited by this paper
• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

  2007cited by this paper
• Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6‐hydroxydopamine toxicity in vivo

  2007cited by this paper
• Impaired expression of postsynaptic density proteins in the hippocampal CA1 region of rats following perinatal hypoxia.

  2007cited by this paper
• Levodopa‐induced dyskinesias

  2007cited by this paper
• Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson’s disease

  2007cited by this paper
• Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.

  2007cited by this paper
• Spatial Learning and Memory Deficits after Whole-Brain Irradiation are Associated with Changes in NMDA Receptor Subunits in the Hippocampus

  2006cited by this paper
• Cortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

  2006cited by this paper
• Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain.

  2006cited by this paper
• Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking

  2006cited by this paper
• Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

  2006cited by this paper
• Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex

  2006cited by this paper
• Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned rats.

  2006cited by this paper
• Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats.

  2005cited by this paper
• Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory.

  2005cited by this paper
• Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies.

  2005cited by this paper
• Modulation of dopamine release by striatal 5‐HT2C receptors

  2005cited by this paper
• Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

  2005cited by this paper
• Serotonergic mechanisms in Parkinson’s disease: opposing results from preclinical and clinical data

  2005cited by this paper
• Alterations in stress-associated behaviors and neurochemical markers in adult rats after neonatal short-lasting local inflammatory insult.

  2005cited by this paper
• Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.

  2005cited by this paper
• Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributions

  2004influential reference
• Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

  2004cited by this paper
• Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.

  2004cited by this paper
• Glutamatergic regulation of long-term grafts of fetal lateral ganglionic eminence in a rat model of Huntington's disease.

  2004cited by this paper
• Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease.

  2004cited by this paper
• Tremor in Parkinson's disease and serotonergic dysfunction An 11 C-WAY 100635 PET study

  2003cited by this paper
• NMDA systems in the amygdala and piriform cortex and nicotinic effects on memory function.

  2003cited by this paper
• Tremor in Parkinson’s disease and serotonergic dysfunction

  2003cited by this paper
• Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism

  2003cited by this paper
• The Physiological Role of 5-HT2A Receptors in Working Memory

  2002cited by this paper
• Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group.

  2002cited by this paper
• Multiplicity of mechanisms of serotonin receptor signal transduction.

  2001cited by this paper
• The pathology of Parkinson's disease.

  2001cited by this paper
• Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6‐OHDA lesion

  2000cited by this paper
• Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

  2000cited by this paper
• Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment.

  2000cited by this paper
• Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain.

  1999cited by this paper
• The “Psychic” Neuron of the Cerebral Cortex

  1999cited by this paper
• Involvement of basal ganglia transmitter systems in movement initiation.

  1998cited by this paper
• Serotonin receptors in cognitive behaviors.

  1997cited by this paper
• Disturbances in higher function in Parkinson's disease.

  1997cited by this paper
• Regulation of serotonin‐facilitated dopamine release in vivo: The role of protein kinase A activating transduction mechanisms

  1996influential reference
• Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study

  1996cited by this paper
• Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease

  1995cited by this paper
• Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.

  1994cited by this paper
• Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.

  1993influential reference
• N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease.

  1991cited by this paper
• A CIOMS ethical code for animal experimentation.

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• New Frontiers

  1934cited by this paper

• The Neurotransmitter Receptor Architecture of the Mouse Olfactory System

  2021cites this paper
• Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat

  2018cites this paper
• Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease

  2018cites this paper
• 5-HT2A Receptors in the Basal Ganglia

  2018cites this paper
• Dopamine, Noradrenaline and Serotonin Receptor Densities in the Striatum of Hemiparkinsonian Rats following Botulinum Neurotoxin-A Injection.

  2018cites this paper
• Preventive treatment with dizocilpine attenuates oedema in a carrageenan model of inflammation: the interaction of glutamatergic and nitrergic signaling

  2018cites this paper
• Dietary Galacto‐Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5‐HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High‐Fat Diet

  2018cites this paper
• Long noncoding RNA GM12371 acts as a transcriptional regulator of synapse function

  2018cites this paper
• Does Dopamine Depletion Trigger a Spreader Lexical-Semantic Activation in Parkinson's Disease? Evidence from a Study Based on Word Fluency Tasks

  2017cites this paper
• Position Emission Tomography/Single‐Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease

  2016cites this paper
• Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.

  2016cites this paper
• Cohort Study on Meniscal Lesions among Airport Baggage Handlers

  2016cites this paper
• Hyperexpressed Netrin-1 Promoted Neural Stem Cells Migration in Mice after Focal Cerebral Ischemia

  2016cites this paper
• 5-HT2A Receptor Binding in the Frontal Cortex of Parkinson's Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study

  2016cites this paper
• Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system

  2015cites this paper
• Neurotransmitter receptor density changes in Pitx3ak mice--a model relevant to Parkinson's disease.

  2015influential citation
• Serotonylation and Transamidation of Other Monoamines.

  2015cites this paper
• Changes in the expression of neurotransmitter receptors in Parkin and DJ-1 knockout mice--A quantitative multireceptor study.

  2015cites this paper
• Correlation of Dopaminergic and Serotonergic Dysfunction in a Rat Model of Parkinson's Disease

  2015cites this paper
• Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.

  2014cites this paper
• Changes in 5-HT2A Receptor Expression in Untreated, de novo Patients with Parkinson's Disease

  2014cites this paper
• Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

  2014cites this paper
• Nitric oxide synthase modulates the antihyperalgesic effect of the NMDA receptor antagonist MK-801 on Carrageenan-induced inflammatory pain in rats.

  2014cites this paper
• Dopaminergic neuron destruction reduces hippocampal serotonin 1A receptor uptake of trans-[(18)F]Mefway.

  2014cites this paper
• 6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences

  2014cites this paper
• Morphine and the canine brain : the influence of morphine on cerebral perfusion and 5-HT2A receptors

  2013cites this paper
• Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.

  2013cites this paper
• DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet.

  2013cites this paper
• The response of juxtacellular labeled GABA interneurons in the basolateral amygdaloid nucleus anterior part to 5-HT₂A/₂C receptor activation is decreased in rats with 6-hydroxydopamine lesions.

  2013influential citation
• Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.

  2013cites this paper
• Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease

  2012cites this paper
• Serotonin receptor subtypes functional regulation and oxidative stress mediated apoptosis in 6 hydroxydopamine lesioned parkinsonian rats functional recovery with serotonin GABA and bone marrow cells

  2012cites this paper
• Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

  2012cites this paper
• Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates.

  2011cites this paper
• The serotonergic system in Parkinson's disease.

  2011cites this paper
• Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

  2011cites this paper
• Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease.

  2011cites this paper
• 6-OHDA lesion models of Parkinson’s disease in the rat

  2011cites this paper
• Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy.

  2011cites this paper
• 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

  2010cites this paper
• Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains.

  2010cites this paper